RUBIUS THERAPEUTICS INC's ticker is RUBY and the CUSIP is 78116T103. A total of 113 filers reported holding RUBIUS THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.09 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $6,546,109 | -60.5% | 38,506,526 | 0.0% | 0.21% | -70.0% |
| Q3 2022 | $16,557,000 | -49.4% | 38,506,526 | 0.0% | 0.70% | -43.5% |
| Q2 2022 | $32,731,000 | -84.6% | 38,506,526 | 0.0% | 1.23% | -75.3% |
| Q1 2022 | $212,171,000 | -43.1% | 38,506,526 | 0.0% | 4.98% | -13.6% |
| Q4 2021 | $372,743,000 | -45.9% | 38,506,526 | 0.0% | 5.76% | -20.1% |
| Q3 2021 | $688,497,000 | -26.8% | 38,506,526 | 0.0% | 7.21% | -39.9% |
| Q2 2021 | $939,945,000 | -7.9% | 38,506,526 | 0.0% | 12.00% | -26.5% |
| Q1 2021 | $1,020,423,000 | +251.1% | 38,506,526 | +0.5% | 16.34% | +208.9% |
| Q4 2020 | $290,671,000 | +51.5% | 38,296,526 | 0.0% | 5.29% | -0.2% |
| Q3 2020 | $191,866,000 | -16.2% | 38,296,526 | 0.0% | 5.30% | -20.3% |
| Q2 2020 | $229,013,000 | +34.4% | 38,296,526 | 0.0% | 6.65% | -16.7% |
| Q1 2020 | $170,419,000 | -53.2% | 38,296,526 | 0.0% | 7.99% | -60.7% |
| Q4 2019 | $363,817,000 | +21.0% | 38,296,526 | 0.0% | 20.34% | +23.7% |
| Q3 2019 | $300,628,000 | -50.1% | 38,296,526 | 0.0% | 16.44% | -36.9% |
| Q2 2019 | $602,404,000 | -13.1% | 38,296,526 | 0.0% | 26.08% | -0.6% |
| Q1 2019 | $693,167,000 | +12.6% | 38,296,526 | 0.0% | 26.23% | -12.8% |
| Q4 2018 | $615,808,000 | -33.0% | 38,296,526 | 0.0% | 30.07% | -50.5% |
| Q3 2018 | $919,117,000 | – | 38,296,526 | – | 60.75% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |